Abstract:Background The overall benefits of the newly introduced family‐based Helicobacter pylori (H. pylori) infection control and management (FBCM) and screen‐and‐treat strategies in preventing multiple upper gastrointestinal diseases at national level in China have not been explored. We investigate the cost‐effectiveness of these strategies in the whole Chinese population. Materials and Methods Decision trees and Markov models of H. pylori infection‐related non‐ulcer dyspepsia (NUD), peptic ulcer disease (PUD), and gastric cancer (GC) were developed to simulate the cost‐effectiveness of these strategies in the whole 494 million households in China. The main outcomes include cost‐effectiveness, life years (LY), quality‐adjusted life year (QALY), and incremental cost‐effectiveness ratio (ICER). Results When compared with no‐screen strategy, both FBCM and screen‐and‐treat strategies reduced the number of new cases of NUD, PUD, PUD‐related deaths, and the prevalence of GC, and cancer‐related deaths. The costs saved by these two strategies were 879 million, quality‐adjusted life years gained were 227 million and 267 million, and life years gained were 59 million and 69 million, respectively. Cost‐effectiveness analysis showed that FBCM strategy costs − 24.75/LY, and screen‐and‐treat strategy costs − 12.71/LY when compared with no‐screen strategy. Compared to the FBCM strategy, the screen‐and‐treat strategy reduced the incidence of H. pylori‐related diseases, added 40 million QALYs, and saved 10 million LYs, but at the increased cost of ‐ ‐ ‐ 14.88/QALY and $59.5/LY when compared with FBCM strategy. The robustness of the results was also verified. Conclusions Both FBCM and screen‐and‐treat strategies are highly cost‐effective in preventing NUD, PUD, and GC than the no‐screen strategy in Chinese families at national level. As FBCM strategy is more practical and efficient, it is expected to play a more important role in preventing familial H. pylori infection and also serves as an excellent reference for other highly infected societies.

Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer

Cost-Effectiveness Analysis of Helicobacter Pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for <i>Helicobacter pylori</i> infection: a protocol of a single-centre, single-blind, randomised clinical trial in China

Effect of Helicobacter Pylori Eradication on Hyperplastic Gastric Polyps: A Systematic Review and Meta‐analysis

Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.

Current Status of Helicobacter Pylori Eradication and Risk Factors for Eradication Failure

Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis

Cost-effectiveness of Helicobacter Pylori Screening to Prevent Gastric Cancer: Markov Decision Analysis

Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-Up

Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis

Gastric Cancer Prevention by Community Eradication of Helicobacter Pylori: a Cluster-Randomized Controlled Trial

Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis

Health Economic Evaluation on Population-Based Helicobacter Pylori Eradication and Endoscopic Screening for Gastric Cancer Prevention.

Family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are highly cost‐effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level

Systematic Review And Meta-Analysis From Chinese Literature: The Association Between Helicobacter Pylori Eradication And Improvement Of Functional Dyspepsia

An Economic Evaluation of Family-Based Versus Traditional Helicobacter pylori Screen-and-Treat Strategy: Based on Real-World Data and Microsimulation Model

Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges

Cost-effectiveness of population based Helicobacter pylori screening to prevent gastric cancer

Therapeutic Effects of Eradicating Helicobacter Pylori on Gastric Hyperplastic Polyps

Maintaining H. pylori Negativity After Eradication Can Consolidate Its Benefit in Gastric Cancer Prevention: A Meta-Analysis

A screen-and-treat strategy for eradication of Helicobacter pylori among patients with family history of gastric cancer in a diverse U.S. population